See also this year's filing and all EDGAR filings for this company.
PDF Report 0001274792_2014_Merrimack_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001274792, Merrimack Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 166,644,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 5,450,000 |
| 2 | PropertyPlantAndEquipmentNet | 13,364,000 |
| 3 | remainder_Assets | 6,959,000 |
| 4 | LiabilitiesCurrent | 57,734,000 |
| 5 | LiabilitiesNoncurrent | 103,427,000 |
| 6 | remainder_Liabilities | 74,384,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 21,187,000 |
| 9 | ResearchAndDevelopmentExpense | 147,139,000 |
| 10 | remainder_Expenses | 10,938,000 |
| 11 | remainder_Revenues | 47,786,000 |
| 12 | remainder_NetIncome | 793,000 |
| 13 | remainder_ComprehensiveNetIncome | -226,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 192,417,000 |
| 1 | Liabilities | 235,545,000 |
| 2 | Expenses | 179,264,000 |
| 3 | Revenues | 47,786,000 |
| 4 | StockholdersEquity | -43,128,000 |
| 5 | NetIncome | -130,685,000 |
| 6 | ComprehensiveNetIncome | -130,798,000 |
| 7 | BaseVar | 328,015,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.05 |
| 9 | EconomicCapitalRatio | 1.29 |
Edgar->Model Mapping
Feature Distribution
Change over Time
